Novo Nordisk settles US probe of kickbacks, disguised salespeople
Bloomberg Novo Nordisk A/S has agreed to settle a US probe of its marketing of diabetes drugs that allegedly included disguising salespeople as medical educators and paying kickbacks to persuade doctors to prescribe its medicines. The allegations were disclosed when a whistle-blower lawsuit was unsealed by a judge. The US Justice Department investigation, which began in 2011, focused on ...
Read More »